GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Guangdong Hybribio Biotech Co Ltd (SZSE:300639) » Definitions » Long-Term Debt

Guangdong Hybribio Biotech Co (SZSE:300639) Long-Term Debt : ¥28.3 Mil (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Guangdong Hybribio Biotech Co Long-Term Debt?

Guangdong Hybribio Biotech Co's Long-Term Debt for the quarter that ended in Mar. 2024 was ¥28.3 Mil.

Guangdong Hybribio Biotech Co's quarterly Long-Term Debt increased from Sep. 2023 (¥20.0 Mil) to Dec. 2023 (¥28.3 Mil) but then stayed the same from Dec. 2023 (¥28.3 Mil) to Mar. 2024 (¥28.3 Mil).

Guangdong Hybribio Biotech Co's annual Long-Term Debt stayed the same from Dec. 2021 (¥0.0 Mil) to Dec. 2022 (¥0.0 Mil) but then increased from Dec. 2022 (¥0.0 Mil) to Dec. 2023 (¥28.3 Mil).


Guangdong Hybribio Biotech Co Long-Term Debt Historical Data

The historical data trend for Guangdong Hybribio Biotech Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangdong Hybribio Biotech Co Long-Term Debt Chart

Guangdong Hybribio Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 28.27

Guangdong Hybribio Biotech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 10.01 20.01 28.27 28.27

Guangdong Hybribio Biotech Co  (SZSE:300639) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


Guangdong Hybribio Biotech Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Guangdong Hybribio Biotech Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Guangdong Hybribio Biotech Co (SZSE:300639) Business Description

Traded in Other Exchanges
N/A
Address
D 5-3-3-4, North High-tech Zone, Economic Development Zone, Chaozhou City, CHN, 521000
Guangdong Hybribio Biotech Co Ltd is a Chinese company engaged in offering vitro diagnostic assays. Its products include in-vitro diagnostic kits, female sample collection kit, DNA extraction kit, and other devices. The company's products help in the infectious pathogens detection and genetic disease detection, including human papillomavirus, thalassemia, G6PD, hearing loss susceptibility, phenylketonuria, and early cancer detection, among others. The company has a business presence in China and various other countries.

Guangdong Hybribio Biotech Co (SZSE:300639) Headlines

No Headlines